Rapid Takeaways From Late-Breaking Science at EuroPCR 2024 Read more about Rapid Takeaways From Late-Breaking Science at EuroPCR 2024
Early Outcomes of a Randomized Non-Inferiority Trial Comparing TAVI Devices: The LANDMARK Trial—Coverage of EuroPCR 2024 Read more about Early Outcomes of a Randomized Non-Inferiority Trial Comparing TAVI Devices: The LANDMARK Trial—Coverage of EuroPCR 2024
First TAVI vs. SAVR Randomized Trial in Younger Low-Risk Patients With Severe Tricuspid or Bicuspid Aortic Valve Stenosis: Results From NOTION-2—Coverage of EuroPCR 2024 Read more about First TAVI vs. SAVR Randomized Trial in Younger Low-Risk Patients With Severe Tricuspid or Bicuspid Aortic Valve Stenosis: Results From NOTION-2—Coverage of EuroPCR 2024
Transcatheter Valve Replacement Outcomes Similar to Surgery in Long-Term Analysis Read more about Transcatheter Valve Replacement Outcomes Similar to Surgery in Long-Term Analysis
Long-Term Outcomes of Transcatheter Aortic Valve vs. Surgical Aortic Valve Replacement—Coverage of EuroPCR 2024 Read more about Long-Term Outcomes of Transcatheter Aortic Valve vs. Surgical Aortic Valve Replacement—Coverage of EuroPCR 2024
SCAI Sends Letter Opposing Proposed Medical Imaging Licensure Legislation in Pennsylvania Read more about SCAI Sends Letter Opposing Proposed Medical Imaging Licensure Legislation in Pennsylvania
Rapid Takeaways From Late-Breaking Science at SCAI Scientific Sessions 2024 Read more about Rapid Takeaways From Late-Breaking Science at SCAI Scientific Sessions 2024
Update From the First-in-Human Study With the Novel DurAVR Biomimetic Transcatheter Heart Valve—Coverage of SCAI Scientific Sessions 2024 Read more about Update From the First-in-Human Study With the Novel DurAVR Biomimetic Transcatheter Heart Valve—Coverage of SCAI Scientific Sessions 2024
National Incidence of Heart Attacks Decline 50% Since 2004, Yet Underrepresented Groups Remain at Highest Risk Read more about National Incidence of Heart Attacks Decline 50% Since 2004, Yet Underrepresented Groups Remain at Highest Risk
